Cargando…

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method”

The current status of screening for gastric cancer-risk (gastritis A, B, C, D) method using combined assay for serum anti-Helicobacter pylori (Hp) IgG antibody and serum pepsinogen (PG) levels, “ABC method”, was reviewed and the latest results of our ongoing trial are reported. It was performed usin...

Descripción completa

Detalles Bibliográficos
Autor principal:	MIKI, Kazumasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japan Academy 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171284/ https://www.ncbi.nlm.nih.gov/pubmed/21785258 http://dx.doi.org/10.2183/pjab.87.405

Ejemplares similares

Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening
por: Chen, Xian-Zhe, et al.
Publicado: (2018)

Long‐term Effect of Helicobacter pylori Infection on Serum Pepsinogens
por: Kikuchi, Shogo, et al.
Publicado: (2000)

Endoscopic gastritis, serum pepsinogen assay, and Helicobacter pylori infection
por: Lee, Sun-Young
Publicado: (2016)

Comparison of Helicobacter pylori stool antigen, salivary IgG, serum IgG, and serum IgM as diagnostic markers of H. pylori infection in children
por: Darma, Andy, et al.
Publicado: (2019)

Comparison of Serum IgG Antibody Test with Gastric Biopsy for the Detection of Helicobacter Pylori Infection among Egyptian Children
por: Shady, Mones M. Abu, et al.
Publicado: (2015)

Sero-prevalence of Helicobacter pylori CagA immunoglobulin G antibody, serum pepsinogens and haemoglobin levels in adults
por: Muhsen, Khitam, et al.
Publicado: (2018)

Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance
por: Choi, Saemi, et al.
Publicado: (2019)

Serum Anti-Helicobacter pylori IgG Antibody Titer in H. pylori-negative Cases with a Different Gastric Mucosal Atrophy Status
por: Adachi, Kyoichi, et al.
Publicado: (2020)

Pepsinogen and Serum IgG Detection Is a Valuable Diagnostic Method for Helicobacter pylori Infection in a Low-Prevalence Country: A Report from Sri Lanka
por: Doohan, Dalla, et al.
Publicado: (2021)

Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests
por: Hamashima, Chisato, et al.
Publicado: (2017)

Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection
por: Kikuchi, Shogo, et al.
Publicado: (2019)

Helicobacter pylori Infection, Serum Pepsinogen Level and Gastric Cancer: A Case‐Control Study in Japan
por: Fukuda, Haruhiko, et al.
Publicado: (1995)

Evaluation of Anti-Helicobacter pylori IgG Antibodies for the Detection of Helicobacter pylori Infection in Different Populations
por: Yu, Jin-Han, et al.
Publicado: (2022)

Age-Specific Gastric Cancer Risk Indicated by the Combination of Helicobacter pylori Sero-Status and Serum Pepsinogen Levels
por: Eybpoosh, Sana, et al.
Publicado: (2015)

Effect of Smoking on Serum Pepsinogen I Level Depends on Serological Status of Helicobacter pylori
por: Tatemichi, Masayuki, et al.
Publicado: (2001)

Predicting the Development of Gastric Neoplasms in a Healthcare Cohort by Combining Helicobacter pylori Antibodies and Serum Pepsinogen: A 5-Year Longitudinal Study
por: Kwak, Min-Sun, et al.
Publicado: (2018)

The value of Helicobacter pylori IgG antibody in estimating the severity of gastritis in children.
por: Sim, J. G., et al.
Publicado: (1995)

Serum Pepsinogen Values in Japanese Junior High School Students With Reference to Helicobacter Pylori Infection
por: Okuda, Masumi, et al.
Publicado: (2020)

Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test
por: Zhou, Jun-peng, et al.
Publicado: (2022)

Correlations between the CagA Antigen and Serum Levels of Anti-Helicobacter pylori IgG and IgA in Children
por: Seo, Ji-Hyun, et al.
Publicado: (2016)

Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer
por: Miki, Kazumasa, et al.
Publicado: (1993)

Analysis of negative result in serum anti-H. pylori IgG antibody test in cases with gastric mucosal atrophy
por: Adachi, Kyoichi, et al.
Publicado: (2016)

Prediction of true Helicobacter pylori-uninfected status using a combination of age, serum antibody and pepsinogen: Logistic regression analysis
por: Takayama, Takako, et al.
Publicado: (2020)

Helicobacter Pylori Infection and Serum Pepsinogen I Concentration in Peptic Ulcer Patients: Effect of Bacterial Eradication
por: Park, Sill Moo, et al.
Publicado: (1996)

Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study
Publicado: (2016)

Prediction of Gastric Cancer Development by Serum Pepsinogen Test and Helicobacter pylori Seropositivity in Eastern Asians: A Systematic Review and Meta-Analysis
por: Terasawa, Teruhiko, et al.
Publicado: (2014)

Role of Serum Pepsinogen II and Helicobacter pylori Status in the Detection of Diffuse-Type Early Gastric Cancer in Young Individuals in South Korea
por: Baek, Sung Min, et al.
Publicado: (2020)

Plasma pepsinogens, antibodies against Helicobacter pylori, and risk of gastric cancer in the Shanghai Women's Health Study Cohort
por: Abnet, C C, et al.
Publicado: (2011)

A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication
por: Osumi, Hiroki, et al.
Publicado: (2017)

Serum pepsinogen II levels are doubled with Helicobacter pylori infection in an asymptomatic population of 40,383 Chinese subjects
por: Yu, Hong, et al.
Publicado: (2021)

Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
por: Kim, Yeon-Ji, et al.
Publicado: (2020)

Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology
por: Gong, Eun Jeong, et al.
Publicado: (2018)

Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups.
por: Knight, T., et al.
Publicado: (1996)

Factors for Negative Result in Serum Anti-Helicobacter pylori IgG Antibody Test in Adult Subjects With Nodular Gastritis: A Single-center Study
por: Adachi, Kyoichi, et al.
Publicado: (2021)

Helicobacter pylori infection, serum pepsinogens as markers of atrophic gastritis, and leukocyte telomere length: a population-based study
por: Muhsen, Khitam, et al.
Publicado: (2019)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Development of an ELISA for Quantitative Detection of Immunoglobulin G (IgG) and IgA Antibodies to Helicobacter pylori for Use in Korean Patients with H. pylori-Associated Diseases
por: Seo, Ji-Hyun, et al.
Publicado: (2013)

Significant association of serum H. pylori IgG antibody titer with kidney function in renal transplanted patients
por: Nasri, Hamid, et al.
Publicado: (2013)

Serum Helicobacter pylori FliD antibody and the risk of gastric cancer
por: Li, Hailin, et al.
Publicado: (2016)

Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
por: De Re, Valli, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sd47sl53ta7q2ab42p4psfni7m